An excellent results,up to expectation. I like the revenue part, as 90% is service revenue and recurring.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025